Information Provided By: 
Fly News Breaks for November 29, 2016
SYK, ZBH
Nov 29, 2016 | 08:52 EDT
Citi analyst Amit Hazan upgraded Zimmer Biomet Holdings to Neutral saying the selection of Tom Price to head Health and Human Services "all but ensures current bundled payment programs may be significantly diluted." This removes a major risk to the U.S. reconstruction market, Hazan tells investors in a research note. He raised his price target for Zimmer shares to $108 from $95. The analyst keeps a Sell rating on Stryker (SYK).
News For ZBH;SYK From the Last 2 Days
There are no results for your query ZBH;SYK
